GGH
FATE icon

GCM Grosvenor Holdings’s Fate Therapeutics FATE Stock Holding History

GCM Grosvenor Holdings’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-495,916
Closed -$1.74M – 21
2024
Q3 		$1.74M Hold
495,916
– – 0.26% 20
2024
Q2 		$1.63M Hold
495,916
– – 0.24% 19
2024
Q1 		$3.64M Hold
495,916
– – 0.56% 18
2023
Q4 		$1.85M Hold
495,916
– – 0.33% 17
2023
Q3 		$1.05M Hold
495,916
– – 0.21% 14
2023
Q2 		$2.36M Hold
495,916
– – 1.02% 12
2023
Q1 		$2.83M Sell
495,916
-541,340
-52% -$3.27M 0.76% 12
2022
Q4 		$10.5M Hold
1,037,256
– – 2.67% 11
2022
Q3 		$23.2M Hold
1,037,256
– – 5.51% 8
2022
Q2 		$25.7M Buy
+1,037,256
New +$28.6M 5.81% 8

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return